Reflections and perspectives on adjuvant treatment in the setting of resected hepatocellular carcinoma

Matteo Davide DONADON, MARCELLO DI MARTINO, Paolo Baroffio, Michela Anna Polidoro

Research output: Contribution to journalArticlepeer-review

Abstract

Hepatectomy is a curative procedure in selected patients affected by hepatocellular carcinoma (HCC). However, recurrence rates are as high as 70% five years after resection, and having a valid postoperative systemic regimen would represent a significant improvement in the care of HCC patients. While burgeoning evidence is emerging around the use of immunotherapy in the setting of resected HCC, little is yet known to allow the widespread use of immunotherapy after surgery. Here, we pointed out some reflections and perspectives on adjuvant strategies for patients with resected HCC and discussed potential benefits and drawbacks.
Original languageEnglish
JournalHepatoma Research
Volume10
DOIs
Publication statusPublished - 2024

Keywords

  • adjuvant chemotherapy
  • HCC
  • Hepatocellular carcinoma
  • immunotherapy
  • surgery for hepatocellular carcinoma

Fingerprint

Dive into the research topics of 'Reflections and perspectives on adjuvant treatment in the setting of resected hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this